NovoCure (NVCR) Asset Utilization Ratio (2015 - 2026)

NovoCure (NVCR) has reported Asset Utilization Ratio for 12 consecutive years, with 0.88 the latest figure, recorded in Q2 2026.

• Quarterly Asset Utilization Ratio rose 74.84% year-over-year to 0.88 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.88 (up 74.84% YoY) and the FY2025 annual result came in at 0.64, up 26.38% from the prior year.
• Asset Utilization Ratio climbed to 0.88 in Q2 2026 per NVCR's latest filing, from 0.85 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for NVCR reached as high as 0.88 in Q2 2026 and fell as low as 0.44 in Q2 2023.
• A 5-year average of 0.52 and a median of 0.47 in 2022 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio fell 7.71% — and 2026, when it jumped 74.84%.
• Year by year, Asset Utilization Ratio stood at 0.45 in 2022, then dropped by 2.27% to 0.44 in 2023, then rose by 10.61% to 0.49 in 2024, then increased by 23.15% to 0.61 in 2025, then surged by 45.94% to 0.88 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.88, 0.85, and 0.61 for Q2 2026, Q1 2026, and Q4 2025 respectively.